• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
PTX 3.85% 5.0¢

PRESCIENT THERAPEUTICS LIMITED

Prescient Therapeutics Limited is an Australia-based clinical-stage oncology company. The... Prescient Therapeutics Limited is an Australia-based clinical-stage oncology company. The Company is engaged in the development of personalized medicine approaches to cancer, including targeted and cellular therapies. Its product pipeline includes PTX-100, PTX-200, OmniCAR, CellPryme-M and CellPryme-A. PTX-100 is a compound with the ability to block a cancer growth enzyme, geranylgeranyl transferase-1 (GGT-1). PTX-100 is in Phase Ib expansion cohort study in T cell lymphomas. PTX-200 is a PH domain inhibitor that inhibits a tumor survival pathway, Akt. PTX-200 is in Phase Ib/II trial in relapsed and refractory AML. OmniCAR is a universal immune receptor platform enabling controllable T-cell activity and multi-antigen targeting with a single-cell product. CellPryme-M is a platform for enhancing cell therapies by producing cells with superior phenotypes. CellPryme-A is an adjuvant therapy designed to be administered to patients alongside cellular immunotherapy.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
PTX 30/04/24 5 1.6K
30/04/24 Last post  Jeffhh Comments Created with Sketch.  5  Views Created with Sketch.  1.6K 
PTX
Daily happenings?.
6 7 8
26/04/24 471 202K
26/04/24 Last post  Scotty598 Comments Created with Sketch.  471  Views Created with Sketch.  202K 
PTX 22/04/24 15 8.3K
22/04/24 Last post  Shellbell Comments Created with Sketch.  15  Views Created with Sketch.  8.3K 
PTX
Live Investor Briefing - today
16/04/24 27 11K
16/04/24 Last post  dalts66 Comments Created with Sketch.  27  Views Created with Sketch.  11K 
PTX
PTX Media related
25 26 27
12/04/24 1.5K 629K
12/04/24 Last post  dalts66 Comments Created with Sketch.  1.5K  Views Created with Sketch.  629K 
PTX
updated chart
53 54 55
10/04/24 3.2K 1.1M
10/04/24 Last post  Mannydee Comments Created with Sketch.  3.2K  Views Created with Sketch.  1.1M 
PTX
Blocking agent
06/04/24 11 4.7K
06/04/24 Last post  Shellbell Comments Created with Sketch.  11  Views Created with Sketch.  4.7K 
PTX 05/04/24 0 471
05/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  471 

See All Discussions arrow Created with Sketch.

Timeline

March 2024 Quarterly Update and Appendix 4C
30 Apr 09:57
 
PTX100 Ph1b results to be presented at specialist congress
08 Apr 12:39
 
Notification of cessation of securities - PTX
05 Apr 12:55
 
Appendix 4D and Half Year Financial Report
23 Feb 10:14
 
December 2023 Quarterly Update and Appendix 4C
31 Jan 11:52
 
PTX-100 Spotlight Presentation
18 Dec 10:53
 
View More arrow Created with Sketch.
(20min delay)
Last
5.0¢
Change
-0.002(3.85%)
Mkt cap ! $40.26M
Open High Low Value Volume
5.2¢ 5.2¢ 4.9¢ $21.91K 440.0K

Buyers (Bids)

No. Vol. Price($)
7 189208 4.9¢
 

Sellers (Offers)

Price($) Vol. No.
5.0¢ 6566 1
View Market Depth
Last trade - 15.43pm 01/05/2024 (20 minute delay) ?
Last
5.0¢
  Change
-0.002 ( 0.00 %)
Open High Low Volume
5.0¢ 5.0¢ 4.9¢ 73482
Last updated 15.59pm 01/05/2024 ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.